We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOG icon
26
Alphabet (Google) Class C
GOOG
$4.09T
$615M 0.52%
10,090,580
-1,186,660
-11% -$70.2M
QQQ icon
27
CALL
Invesco QQQ Trust
QQQ
$445B
$611M 0.52%
3,237,400
+1,287,300
+66% +$244M
META icon
28
Meta Platforms (Facebook)
META
$1.51T
$603M 0.51%
3,383,442
-47,613
-1% -$9.05M
ALC icon
29
Alcon
ALC
$33.7B
$584M 0.49%
10,019,548
-251,386
-2% -$15.1M
NKE icon
30
Nike
NKE
$63.8B
$560M 0.47%
5,965,336
+2,388,603
+67% +$205M
VXF icon
31
Vanguard Extended Market ETF
VXF
$30.4B
$547M 0.46%
4,700,936
+4,696,364
+102,720% +$553M
BMY icon
32
Bristol-Myers Squibb
BMY
$130B
$533M 0.45%
10,513,377
-1,372,851
-12% -$64.5M
HYG icon
33
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$531M 0.45%
6,090,000
-1,133,500
-16% -$98.4M
MRK icon
34
Merck
MRK
$326B
$506M 0.43%
6,303,881
+603,583
+11% +$48.4M
PFE icon
35
Pfizer
PFE
$144B
$484M 0.41%
14,208,143
+1,217,853
+9% +$44.3M
RTX icon
36
RTX Corp
RTX
$293B
$482M 0.41%
5,605,404
+2,386,983
+74% +$198M
INTC icon
37
Intel
INTC
$437B
$471M 0.4%
9,143,361
-546,293
-6% -$26.9M
QQQ icon
38
Invesco QQQ Trust
QQQ
$445B
$463M 0.39%
2,449,643
+1,476,636
+152% +$280M
AAPL icon
39
PUT
Apple
AAPL
$4.99T
$454M 0.38%
8,112,800
+255,600
+3% +$13.4M
KO icon
40
Coca-Cola
KO
$378B
$444M 0.37%
8,154,120
-85,203
-1% -$4.56M
VZ icon
41
Verizon
VZ
$202B
$441M 0.37%
7,303,421
+924,750
+14% +$53.3M
CVX icon
42
Chevron
CVX
$375B
$438M 0.37%
3,696,250
+248,318
+7% +$30.2M
ABBV icon
43
AbbVie
ABBV
$470B
$428M 0.36%
5,657,898
+2,917,243
+106% +$200M
ETR icon
44
Entergy
ETR
$52.9B
$428M 0.36%
7,293,922
-2,301,478
-24% -$126M
BRK.B icon
45
Berkshire Hathaway Class B
BRK.B
$1.1T
$402M 0.34%
1,931,712
-10,438
-0.5% -$2.15M
CSCO icon
46
Cisco
CSCO
$456B
$394M 0.33%
7,976,025
-397,731
-5% -$20.7M
DIS icon
47
Walt Disney
DIS
$172B
$383M 0.32%
2,938,426
+286,709
+11% +$39.6M
EFA icon
48
CALL
iShares MSCI EAFE ETF
EFA
$76.8B
$377M 0.32%
5,787,600
+371,800
+7% +$24M
MA icon
49
Mastercard
MA
$496B
$376M 0.32%
1,384,709
-193,407
-12% -$53.3M
CTXS
50
DELISTED
Citrix Systems Inc
CTXS
$376M 0.32%
3,895,870
+1,401,706
+56% +$134M

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.